CD4 and atrial fibrillation: However, a caveat of including dams from multiple treatment groups is a potential confounding factor since all 3 of the dams receiving the high RhCMV-neutralizing IgG infusion were AF-negative and all 6 of the CD4-depleted dams without IgG infusion were AF-positive.